Print
What New Research Reveals
Every year, millions line up for the flu shot, trusting it will cut their chances of catching influenza. But surprising new research from the Cleveland Clinic suggests the 2024–2025 flu vaccine may have done the opposite.
Instead of reducing illness, it appears the shot actually increased the risk of getting sick. That finding raises sharp questions about vaccine effectiveness, public health messaging, and what flu prevention should look like going forward.
A Look at the Cleveland Clinic Study
The Cleveland Clinic tracked more than 53,000 employees during the 2024–2025 respiratory season. Roughly 82 percent—over 43,000 people—received a flu shot. For 25 weeks, researchers compared infection rates between those who were vaccinated and those who weren’t.
At first, infection rates looked similar. But as the season went on, a troubling pattern appeared: vaccinated workers were more likely to get the flu. The vaccine showed what’s called “negative efficacy”—instead of protection, it increased the risk.
Vaccinated individuals were 26.9 percent more likely to catch influenza than those who skipped the shot. That’s not just a weak benefit—it’s a reversal of what most expect a vaccine to deliver.
What “Negative Efficacy” Really Means
The term “negative efficacy” can sound technical, but it’s simple. It means that instead of helping, the vaccine raised the odds of infection. In this case, by nearly 27 percent.
Researchers calculated the chance of this result being random at about seven in a thousand. Statistically, that’s very unlikely to happen by accident. The data strongly suggests a real problem, not a fluke.
Echoes of COVID Vaccine Findings
This isn’t the first time Cleveland Clinic scientists have reported results like this. In 2023, they published a major study on COVID-19 vaccines. That study found that people who had received more doses were actually more likely to catch COVID later on.
A clear chart from that research showed infection risk climbing with each extra shot. Natural immunity, on the other hand, provided stronger protection, especially for people who had recently recovered from a similar variant.
The new flu study looks strikingly similar, again pointing to negative efficacy. Taken together, the findings challenge the wisdom of depending on repeated vaccination as the main line of defense against respiratory viruses.
Why Would the Flu Shot Backfire?
No one has a clear answer for why a vaccine meant to protect could increase risk. But researchers have floated a few possibilities. One is strain mismatch. Because flu shots are designed months in advance, if the virus drifts by the time flu season arrives, the vaccine may not match well.
Another theory is immune interference. Some scientists suggest that repeated vaccination could confuse or weaken immune defenses, especially compared to natural immunity. Importantly, the Cleveland study adjusted for age, sex, job type, and location, making it harder to dismiss the results as bias.
More Than an Ohio Problem
Skeptics might think this is just a quirk of the Cleveland Clinic’s workforce. But the researchers stressed that the results are generalizable. In other words, the same negative efficacy could apply to working-age adults across the United States. That means instead of reducing flu cases, the 2024–2025 campaign may have increased them nationwide.
The Serious Side of Influenza
Some may brush off the flu as a seasonal nuisance. But influenza is far from harmless. In 2017, it caused an estimated 145,000 deaths worldwide. And the 1918 Spanish flu killed more than 50 million people, with a fatality rate vastly higher than typical seasonal strains. Against that backdrop, the idea of a vaccine that actually raises infection risk takes on far greater weight.
The Type of Vaccine Used
The vaccine in question was a trivalent inactivated shot. It contained three types of killed viruses—H3N2, H1N1, and influenza B—to spark immune protection.
In theory, it’s a sound strategy: expose the body to a harmless version so it’s ready for the real one. But the challenge is timing. These vaccines are manufactured months before flu season, and if the virus drifts, the vaccine may miss the mark—or worse, backfire.
A Policy Challenge
Public health officials have long urged annual flu shots as almost a civic duty. But there’s a structural issue at play.
Agencies that recommend vaccines often rely on funding from the same companies that sell them. Critics argue this creates conflicts of interest, blurring the line between science and profit. Independent studies like Cleveland Clinic’s become even more important in keeping the system honest.
The Push Toward mRNA Flu Shots
With inactivated flu shots showing negative efficacy, some researchers argue it’s time to move toward mRNA-based vaccines, modeled after the COVID shots.
Supporters say mRNA versions could be updated more quickly and match circulating strains better. But others point to the controversies and side effect concerns that surrounded mRNA COVID vaccines, warning that applying the same technology to flu could carry major risks.
What This Means for Flu Prevention
The big takeaway is sobering: in the 2024–2025 season, the flu shot didn’t just fail—it raised infection risk by nearly 27 percent.
That doesn’t mean flu is harmless, or that no vaccine could ever work. But it does mean public health needs to face the data honestly. Promoting a shot that may increase illness without disclosing that possibility erodes a lot of trust.
Rethinking Protection
For decades, the seasonal flu shot has been promoted as a yearly necessity.
But if studies like this hold up, the assumption that “more vaccines equal more protection” doesn’t stand. The Cleveland Clinic’s findings suggest it’s time to look harder at natural immunity, healthy living, and prevention strategies that don’t rely so heavily on annual injections.
More doesn’t always mean better—and in this case, it may mean worse.
